GO:0071752 secretory dimeric IgA immunoglobulin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071752 describes the secretory dimeric IgA immunoglobulin complex, a cellular component formed when two IgA monomers are joined by J chain and wrapped by the polymeric immunoglobulin receptor-derived secretory component.
• Secretory IgA (SIgA) is the dominant antibody at mucosal surfaces, where it neutralizes pathogens and shapes the intestinal microbiota.
• Assembly requires dimerization of IgA, incorporation of the J chain, and covalent and non-covalent association with secretory component.
• The complex is transported across epithelial cells by the polymeric immunoglobulin receptor (pIgR) via transcytosis.
• Structural studies have defined the IgA1 and IgA2 dimer interfaces and the secretory component binding sites at near-atomic resolution.
• Defects in SIgA production or transport are linked to selective IgA deficiency and mucosal immune dysregulation.
Description
The secretory dimeric IgA immunoglobulin complex (GO:0071752) is the molecular form of immunoglobulin A that carries out immune exclusion at mucosal surfaces. It consists of two IgA monomers linked by a joining (J) chain and associated with the extracellular portion of the polymeric immunoglobulin receptor, known as the secretory component. This complex is the principal antibody species in saliva, tears, milk, and intestinal secretions, where it protects epithelial barriers from pathogens and toxins. Because it is a cellular component, GO:0071752 is used to annotate the assembled, secreted antibody complex rather than its individual polypeptide chains. Researchers studying mucosal immunity, vaccine responses, and epithelial transport rely on this term to describe the functional antibody unit that is secreted into mucosal fluids. Understanding its structure and assembly is therefore central to mucosal immunology and to the development of oral and intranasal vaccines.
secretory dimeric IgA immunoglobulin complex At A Glance
| GO ID | GO:0071752 |
|---|---|
| GO term | secretory dimeric IgA immunoglobulin complex |
| Ontology | cellular_component |
| Synonym | secretory dimeric IgA1 antibody; secretory dimeric IgA antibody |
| Major function | Mucosal immune exclusion and antigen neutralization at epithelial surfaces |
| Composition | Two IgA monomers, one J chain, and one secretory component |
| Assembly site | Mucosal epithelial cells and plasma cells of the lamina propria |
| Transport | pIgR-mediated transcytosis across epithelial cells |
What Is GO:0071752?
GO:0071752 defines the secretory dimeric IgA immunoglobulin complex as a dimeric form of the secretory IgA immunoglobulin complex. In practical terms, it is the assembled antibody complex composed of two IgA heavy-light chain monomers, one J chain, and one secretory component molecule, which is secreted by mucosal epithelial cells.
Why Is secretory dimeric IgA immunoglobulin complex Important in Cell Biology?
The secretory dimeric IgA immunoglobulin complex is the first line of adaptive immune defense at mucosal surfaces, which cover the majority of the body's surface area exposed to the environment. It neutralizes viruses, bacteria, and toxins without triggering inflammatory responses, making it essential for immune homeostasis in the gut and airways. Its unique structure, including the J chain and secretory component, confers resistance to proteolytic degradation in mucosal secretions. Defects in its production or transport are associated with selective IgA deficiency and increased susceptibility to mucosal infections. Consequently, GO:0071752 is a key annotation for studies of mucosal immunity, vaccine design, and epithelial biology.
• Provides immune exclusion at mucosal surfaces, preventing pathogen attachment to epithelial cells.
• Dominant antibody in human milk, saliva, tears, and intestinal secretions.
• Secretory component protects the complex from proteolytic degradation in mucosal fluids.
• J chain is required for dimerization and for binding to the polymeric immunoglobulin receptor.
• pIgR-mediated transcytosis delivers the complex from the lamina propria to the mucosal lumen.
• Selective IgA deficiency is the most common primary immunodeficiency and involves defective SIgA production.
• Stress and neuroendocrine factors can modulate intestinal SIgA levels.
• Structural knowledge of the complex informs vaccine strategies that target mucosal immunity.
• The complex is a model for studying antibody assembly and epithelial transport.
• GO:0071752 supports annotation of mucosal immune responses in transcriptomic and proteomic studies.
Structure and Composition of secretory dimeric IgA immunoglobulin complex
IgA monomer structure
In simple terms: Each IgA molecule is built from two heavy chains and two light chains, forming a Y-shaped antibody unit.
The basic building block of the secretory dimeric IgA complex is the IgA monomer, a four-chain immunoglobulin composed of two heavy chains and two light chains. Humans have two IgA subclasses, IgA1 and IgA2, which differ in the length and glycosylation of the hinge region. The monomer contains two antigen-binding Fab arms and an Fc region that mediates effector functions.
J chain-mediated dimerization
In simple terms: A small protein called the J chain links two IgA monomers together into a dimer.
Dimerization of IgA is mediated by the joining (J) chain, a small polypeptide that forms disulfide bonds with the tailpieces of two IgA heavy chains. The J chain is essential for the formation of the dimeric IgA complex and for its subsequent interaction with the polymeric immunoglobulin receptor. Structural studies have revealed the precise arrangement of the J chain within the dimer interface.
Secretory component association
In simple terms: The secretory component is a piece of the receptor that wraps around the IgA dimer, stabilizing it in mucosal fluids.
The secretory component is the extracellular domain of the polymeric immunoglobulin receptor (pIgR) that remains bound to dimeric IgA after transcytosis. It associates with the IgA dimer through covalent and non-covalent interactions, forming the complete secretory dimeric IgA complex. The secretory component protects the complex from proteolytic cleavage and helps anchor it in mucus.
Overall architecture of the complex
In simple terms: The finished secretory IgA complex looks like two Y-shaped antibodies joined together and wrapped by a protective protein.
Cryo-electron microscopy and X-ray crystallography have revealed the overall architecture of the secretory dimeric IgA complex, showing the two IgA monomers arranged in a head-to-tail orientation with the J chain at the center and the secretory component wrapping around the Fc regions. The complex is asymmetric and flexible, which may facilitate antigen binding and immune exclusion. These structural insights are critical for understanding how the complex functions in mucosal immunity.
Key Genes Involved in GO:0071752 secretory dimeric IgA immunoglobulin complex
The following genes and proteins are central to the assembly, transport, and function of the secretory dimeric IgA immunoglobulin complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IGHA1 | Encodes the IgA1 heavy chain constant region | Determines IgA1 subclass structure and glycosylation |
| IGHA2 | Encodes the IgA2 heavy chain constant region | Determines IgA2 subclass structure and stability |
| IGKC | Encodes the immunoglobulin kappa light chain | Forms the light chain of IgA monomers |
| IGLC1 | Encodes the immunoglobulin lambda light chain | Alternative light chain of IgA monomers |
| JCHAIN | Encodes the joining chain that links IgA monomers | Essential for dimerization and pIgR binding |
| PIGR | Encodes the polymeric immunoglobulin receptor | Mediates transcytosis and provides secretory component |
| TNFRSF13B | Encodes TACI, a regulator of IgA class switching | Mutations linked to IgA deficiency |
| CD40 | Costimulatory receptor for B cell activation | Required for IgA class switch recombination |
| CD40LG | Ligand for CD40 on T cells | Defects cause hyper-IgM syndrome with IgA deficiency |
| AICDA | Encodes activation-induced cytidine deaminase | Required for class switch recombination to IgA |
| MSH2 | DNA mismatch repair protein | Involved in somatic hypermutation of IgA genes |
| PRDM1 | Encodes BLIMP1, a plasma cell transcription factor | Drives IgA plasma cell differentiation |
| XBP1 | Transcription factor for plasma cell differentiation | Supports high-level IgA secretion |
| IRF4 | Transcription factor in plasma cells | Regulates IgA production |
| IL10 | Cytokine promoting IgA class switching | Modulates mucosal IgA responses |
| TGFB1 | Cytokine inducing IgA class switching | Key regulator of mucosal IgA |
| RETNLB | Resistin-like molecule beta | Promotes IgA production in the gut |
| MUC2 | Mucin 2, major component of intestinal mucus | Interacts with SIgA in the mucus layer |
How Is secretory dimeric IgA immunoglobulin complex Regulated?
The production and assembly of the secretory dimeric IgA immunoglobulin complex are regulated at multiple levels. Class switch recombination to IgA in B cells requires cytokines such as TGF-beta and IL-10, as well as CD40-CD40L costimulation. The transcription factors BLIMP1, XBP1, and IRF4 drive plasma cell differentiation and high-level IgA secretion. Expression of the polymeric immunoglobulin receptor (PIGR) on epithelial cells is upregulated by cytokines and microbial signals, controlling the rate of transcytosis. Stress and neuroendocrine factors can modulate intestinal SIgA levels, linking the nervous system to mucosal immunity. Additionally, the J chain is required for dimerization and for efficient binding to pIgR, so its expression is a key checkpoint in complex assembly.
secretory dimeric IgA immunoglobulin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGR | Mucosal infections, impaired IgA transport | Pigr knockout mouse or epithelial cell line |
| JCHAIN | Defective IgA dimerization, IgA deficiency | Jchain knockout mouse |
| TNFRSF13B | Selective IgA deficiency, common variable immunodeficiency | Tnfrsf13b mutant mouse |
| AICDA | Hyper-IgM syndrome with IgA deficiency | Aicda knockout mouse |
| TGFB1 | Mucosal immune dysregulation, IgA deficiency | Tgfb1 conditional knockout mouse |
Selective IgA deficiency
Selective IgA deficiency is the most common primary immunodeficiency, characterized by serum IgA levels below 0.05 mg/mL with normal IgG and IgM. Affected individuals often have defective production of secretory dimeric IgA, leading to recurrent mucosal infections and increased risk of autoimmune and allergic diseases. The molecular causes include defects in class switch recombination, plasma cell differentiation, and cytokine signaling.
Mucosal infections and dysbiosis
Reduced or absent secretory dimeric IgA at mucosal surfaces impairs immune exclusion of pathogens and alters the composition of the commensal microbiota. This can lead to increased susceptibility to respiratory and gastrointestinal infections, as well as inflammatory conditions such as inflammatory bowel disease. Stress-induced changes in SIgA levels have also been linked to altered intestinal barrier function.
Vaccine and therapeutic implications
Because secretory dimeric IgA is the primary mediator of mucosal immunity, understanding its assembly and transport is critical for the development of mucosal vaccines and antibody-based therapeutics. Structural studies of the complex have identified key interaction sites that could be targeted to enhance or mimic SIgA function. Recombinant secretory component and dimeric IgA are being explored as potential therapeutics for mucosal infections.
From secretory dimeric IgA immunoglobulin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of J chain in IgA dimerization | Jchain knockout mouse or IgA-producing cell line |
| Function of pIgR in transcytosis | Pigr knockout mouse or polarized epithelial cells |
| Structural requirements for secretory component binding | Recombinant IgA and pIgR fragments in vitro |
| Effect of IgA deficiency on microbiota | IgA-deficient mouse models |
| Regulation of IgA class switching | B cell cultures with cytokine stimulation |
| Mucosal vaccine responses | Immunization of wild-type and knockout mice |
How to Study the secretory dimeric IgA immunoglobulin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | Three-dimensional structure of the complex | Determining assembly architecture |
| X-ray crystallography | Atomic structure of protein interfaces | Mapping IgA-J chain and IgA-secretory component contacts |
| Surface plasmon resonance | Binding affinity and kinetics | Measuring dimeric IgA-secretory component interaction |
| ELISA | Concentration of secretory IgA | Diagnosing IgA deficiency and monitoring mucosal immunity |
| Transcytosis assay | Rate of pIgR-mediated transport | Studying epithelial transport of dimeric IgA |
| Western blot | Protein expression and assembly | Detecting J chain and secretory component in complexes |
| Flow cytometry | Cell surface pIgR expression | Analyzing epithelial cell polarization |
| Mass spectrometry | Glycosylation and composition | Characterizing IgA subclasses and post-translational modifications |
Structural biology of the complex
Cryo-electron microscopy and X-ray crystallography have been used to determine the structures of secretory and dimeric IgA, revealing the arrangement of IgA monomers, J chain, and secretory component. These methods provide atomic-level details of the interaction interfaces and are essential for understanding how the complex assembles and functions.
Biochemical assays for assembly and binding
Surface plasmon resonance, isothermal titration calorimetry, and pull-down assays are used to measure the binding affinity between dimeric IgA and secretory component. These techniques help define the biochemical requirements for complex formation and stability.
Cell-based transport assays
Polarized epithelial cell monolayers grown on Transwell filters are used to study pIgR-mediated transcytosis of dimeric IgA. This system allows measurement of transport rates and the effects of mutations in pIgR or IgA.
Quantification of SIgA in mucosal fluids
ELISA and other immunoassays are used to quantify secretory IgA in saliva, tears, milk, and intestinal washes. These methods are important for diagnosing IgA deficiency and for monitoring mucosal immune responses.
How CRISPR Can Be Used to Study GO:0071752 secretory dimeric IgA immunoglobulin complex
Knockout
CRISPR knockout of JCHAIN or PIGR in cell lines or mice can abolish the formation of the secretory dimeric IgA complex, providing models to study its function in mucosal immunity. Knockout of IgA heavy chain genes (IGHA1, IGHA2) eliminates the substrate for complex assembly.
Point Mutation
Point mutations can be introduced into the J chain or secretory component binding sites to dissect the structural requirements for complex assembly and stability. For example, mutating cysteine residues involved in disulfide bonds can test their role in dimerization.
Knock-in
Knock-in of tagged versions of IgA heavy chain or J chain allows visualization and purification of the secretory dimeric IgA complex from cells and tissues. This approach can also be used to introduce human IgA genes into mouse models for translational studies.
Overexpression
Overexpression of PIGR in epithelial cells or of J chain in IgA-producing cells can enhance the production and secretion of the secretory dimeric IgA complex, facilitating biochemical and structural studies.
How EDITGENE Supports secretory dimeric IgA immunoglobulin complex Research
Researchers studying secretory dimeric IgA immunoglobulin complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, transport, or mucosal immune function. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell and animal models, enabling rigorous functional validation of genes such as JCHAIN, PIGR, and IGHA1.
Contact EDITGENE today to design your custom CRISPR model for secretory dimeric IgA immunoglobulin complex research.
Frequently Asked Questions About secretory dimeric IgA immunoglobulin complex
What is GO:0071752?
GO:0071752 is the Gene Ontology term for the secretory dimeric IgA immunoglobulin complex, a cellular component consisting of two IgA monomers linked by J chain and associated with secretory component.
What is secretory dimeric IgA immunoglobulin complex?
It is the predominant antibody complex at mucosal surfaces, formed by dimerization of IgA and addition of the secretory component, which protects it from degradation.
What genes are involved in secretory dimeric IgA immunoglobulin complex?
Key genes include IGHA1, IGHA2, JCHAIN, and PIGR, which encode the IgA heavy chains, J chain, and polymeric immunoglobulin receptor, respectively.
How is secretory dimeric IgA assembled?
Two IgA monomers are joined by the J chain, and the complex then binds to pIgR on epithelial cells, which is cleaved to become the secretory component.
What is the role of the J chain in secretory IgA?
The J chain mediates dimerization of IgA and is required for binding to the polymeric immunoglobulin receptor.
What is the function of the secretory component?
The secretory component is the extracellular portion of pIgR that remains bound to dimeric IgA, protecting it from proteolysis and anchoring it in mucus.
Which diseases are associated with secretory dimeric IgA deficiency?
Selective IgA deficiency is the most common primary immunodeficiency and is associated with defective secretory IgA production, leading to mucosal infections and autoimmune conditions.
How is secretory IgA transported across epithelial cells?
Dimeric IgA binds to pIgR on the basolateral surface of epithelial cells and is transcytosed to the apical surface, where the complex is released.
What methods are used to study secretory dimeric IgA?
Structural biology (cryo-EM, crystallography), biochemical binding assays, cell-based transcytosis assays, and ELISA are commonly used.
Can CRISPR be used to study secretory dimeric IgA?
Yes, CRISPR knockout, knock-in, and overexpression models can be used to study the function of genes like JCHAIN and PIGR in complex assembly and transport.
Conclusion
The secretory dimeric IgA immunoglobulin complex (GO:0071752) is a uniquely adapted antibody complex that provides immune protection at mucosal surfaces. Its assembly requires the coordinated action of IgA heavy chains, J chain, and the polymeric immunoglobulin receptor, and its structure has been elucidated by recent advances in structural biology. Dysregulation of this complex is linked to selective IgA deficiency and mucosal immune disorders. Continued research using CRISPR-based models and advanced biochemical methods will further clarify its roles in health and disease.
References
- 1. Yel L. 2010. Selective IgA deficiency.. J Clin Immunol 30(1):10-6 PMID: 20101521
- 2. Asano M et al.. 2011. Polymeric immunoglobulin receptor.. J Oral Sci 53(2):147-56 PMID: 21712618
- 3. Kumar Bharathkar S et al.. 2020. The structures of secretory and dimeric immunoglobulin A.. Elife 9 PMID: 33107820
- 4. Kumar Bharathkar S et al.. 2024. Structural and Biochemical Requirements for Secretory Component Interactions with Dimeric IgA.. J Immunol 213(2):226-234 PMID: 38809110
- 5. Kumar Bharathkar S et al.. 2024. Structural and biochemical requirements for secretory component interactions with dimeric Immunoglobulin A.. bioRxiv PMID: 38014291
- 6. Kumar N et al.. 2020. Structure of the secretory immunoglobulin A core.. Science 367(6481):1008-1014 PMID: 32029686
- 7. Brandtzaeg P. 1981. Transport models for secretory IgA and secretory IgM.. Clin Exp Immunol 44(2):221-32 PMID: 6118214
- 8. Campos-Rodríguez R et al.. 2013. Stress modulates intestinal secretory immunoglobulin A.. Front Integr Neurosci 7:86 PMID: 24348350
